Thoracic Oncology for the Cardiothoracic Surgeon: What You Really Need to Know in 2025
All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.
Moderators
Mara Antonoff, MD
Disclosure(s): BMS, AZ, Merck, Ethicon: Advisory Board (Ongoing), Consultant (Ongoing), Speaker (Ongoing)
Brian Mitzman, MD, MS
Disclosure(s): Intuitive Surgical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Presentations
- When to Refer for Neoadjuvant
Stephen Broderick, MD, MPHS
Disclosure(s): Astrazeneca: Advisory Board (Terminated, February 1, 2024); Bristol Meyers Squibb: Advisory Board (Ongoing), Consultant (Ongoing)
- When to Do a Sublobar Resection
Daniel Boffa, MD
Disclosure(s): Epic Sciences: Consultant (Ongoing); Iovance: Advisory Board (Ongoing)
- When to Refer for Adjuvant XRT/Systemic
Linda W. Martin, MD, MPH
Disclosure(s): BMS: Speaker (Terminated, May 6, 2024)
- What's Adequate Staging/Profiling?
DuyKhanh P. Ceppa, MD
Disclosure(s): Medtronic: Consultant (Ongoing); Aztra zeneka: Advisory Board (Ongoing), Consultant (Ongoing); Cook Medical: Consultant (Ongoing)
- Discussion
Available Credit
- 1.00 ABS Accredited CME
- 1.00 ABTS Accredited CME
- 1.00 AMA PRA Category 1 Credit™
Price
All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.
Moderators
Mara Antonoff, MD
Disclosure(s): BMS, AZ, Merck, Ethicon: Advisory Board (Ongoing), Consultant (Ongoing), Speaker (Ongoing)
Brian Mitzman, MD, MS
Disclosure(s): Intuitive Surgical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Presentations
- When to Refer for Neoadjuvant
Stephen Broderick, MD, MPHS
Disclosure(s): Astrazeneca: Advisory Board (Terminated, February 1, 2024); Bristol Meyers Squibb: Advisory Board (Ongoing), Consultant (Ongoing)
- When to Do a Sublobar Resection
Daniel Boffa, MD
Disclosure(s): Epic Sciences: Consultant (Ongoing); Iovance: Advisory Board (Ongoing)
- When to Refer for Adjuvant XRT/Systemic
Linda W. Martin, MD, MPH
Disclosure(s): BMS: Speaker (Terminated, May 6, 2024)
- What's Adequate Staging/Profiling?
DuyKhanh P. Ceppa, MD
Disclosure(s): Medtronic: Consultant (Ongoing); Aztra zeneka: Advisory Board (Ongoing), Consultant (Ongoing); Cook Medical: Consultant (Ongoing)
- Discussion